CFDE Data Portal | Search LINC02731

	Label	Description
	LINC02731 Gene (Entity type)	ENSG00000204241 - long intergenic non-protein coding RNA 2731
	GSE195663 cisplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199859 A-7 HCA7 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE134029 cisplatin 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE144279 GSE144280 MBD5 knockdown neuron 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE164505 GSE164506 indisulam 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Liver 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx

LINC02731

ENSG00000204241 - long intergenic non-protein coding RNA 2731

GSE195663 cisplatin 7 v 1 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 3 v 1 human dn

A Gene Set from LINCS

GSE199859 A-7 HCA7 1 v 0 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human dn

A Gene Set from LINCS

GSE134029 cisplatin 3 v 1 human up

A Gene Set from LINCS

GSE144279 GSE144280 MBD5 knockdown neuron 0 v 3 human dn

A Gene Set from LINCS

GSE164505 GSE164506 indisulam 3 v 2 human dn

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 4 human dn

A Gene Set from LINCS

GTEx Liver 20-29 vs 30-39 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.